Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Teplizumab approval for type 1 diabetes in the USA.
Beran D, Abidha C, Adler A, de Beaufort C, Lepeska M, Levitt N, Pfiester E, Zafra-Tanaka JH, Gale EA. Beran D, et al. Among authors: gale ea. Lancet Diabetes Endocrinol. 2023 Feb;11(2):78-80. doi: 10.1016/S2213-8587(22)00384-9. Epub 2023 Jan 6. Lancet Diabetes Endocrinol. 2023. PMID: 36623522 No abstract available.
The insulin market reaches 100.
Beran D, Gale EAM, Yudkin JS. Beran D, et al. Among authors: gale eam. Diabetologia. 2022 Jun;65(6):931-935. doi: 10.1007/s00125-022-05680-y. Epub 2022 Mar 11. Diabetologia. 2022. PMID: 35275238 Free PMC article. No abstract available.
Diabetes and the WHO Model List of Essential Medicines.
Beran D, Besançon S, Ewen M, Gale EAM, Lazo-Porras M, Lepeska M, Lipska K, Zafra-Tanaka J, Zhaparova A, Yudkin JS. Beran D, et al. Among authors: gale eam. Lancet Diabetes Endocrinol. 2022 Jan;10(1):17-18. doi: 10.1016/S2213-8587(21)00323-5. Lancet Diabetes Endocrinol. 2022. PMID: 34919864 No abstract available.
Diabetes in sub-Saharan Africa: from clinical care to health policy.
Atun R, Davies JI, Gale EAM, Bärnighausen T, Beran D, Kengne AP, Levitt NS, Mangugu FW, Nyirenda MJ, Ogle GD, Ramaiya K, Sewankambo NK, Sobngwi E, Tesfaye S, Yudkin JS, Basu S, Bommer C, Heesemann E, Manne-Goehler J, Postolovska I, Sagalova V, Vollmer S, Abbas ZG, Ammon B, Angamo MT, Annamreddi A, Awasthi A, Besançon S, Bhadriraju S, Binagwaho A, Burgess PI, Burton MJ, Chai J, Chilunga FP, Chipendo P, Conn A, Joel DR, Eagan AW, Gishoma C, Ho J, Jong S, Kakarmath SS, Khan Y, Kharel R, Kyle MA, Lee SC, Lichtman A, Malm CP, Mbaye MN, Muhimpundu MA, Mwagomba BM, Mwangi KJ, Nair M, Niyonsenga SP, Njuguna B, Okafor OLO, Okunade O, Park PH, Pastakia SD, Pekny C, Reja A, Rotimi CN, Rwunganira S, Sando D, Sarriera G, Sharma A, Sidibe A, Siraj ES, Syed AS, Van Acker K, Werfalli M. Atun R, et al. Among authors: gale eam. Lancet Diabetes Endocrinol. 2017 Aug;5(8):622-667. doi: 10.1016/S2213-8587(17)30181-X. Epub 2017 Jul 5. Lancet Diabetes Endocrinol. 2017. PMID: 28688818 Review. No abstract available.
224 results